Evaluation the result of flouroscopy-guided sclerotherapy in treating superficial venous malformation

Dr Mai Thi Quynh1, professor Pham Minh Thong1, Dr Vu Dang Luu1, Dr le Minh Nguyet2
1 Hanoi Medical University
2 Radiology Center – Bach Mai Hospital

Main Article Content

Abstract

Objective: Describe characteristics imaging of superficial venous malformation (VM) on flouroscopy and evaluate effectiveness of foam sclerotherapy.
Methods: Prospective and retroprestive cohort from November 2015 till July 2019 on 17 patients with VM treated by flouroscopy-guided sclerotherapy with 21 lesions and 46 seasons sclerotherapy. Evualating results of treatment based on improvement in symtomps ( pain- Visual Analogue Score) and imaging ( MRI- repeat MRI after last season for 6 months . There are 4 grade in improvement in imaging: excellent ( reduction in size of lesion over 90 %), good ( reduce 50 -90 %), average
( 10-50 %) and no reponse ( less 10 %). Evualating recurrence based on increasing pain score (VAS) or size in MRI. Using SPSS 20.0 to analize and process data.
Results: 17 patients (7 males and 11 females) with VM were involved in our study. Patients were a mean of 26.5± 12.9 years old (range: from 6 to 59). Evualated by digital subtraction angiography, the lesion were categorized into 4 types according to the venous drainage features. Of the 21 lesion: 3/21 had type I (14.3 %), 12/21 had type II (57.1%); 2/21 had type III (9.5 %) and 4/21 had type IV (19 %). Total seasons are 46. 8/21lesions (38.1 %) achieved excellent response, 9/21 (42.9 %)
achieved good response, 3/21 (14.3 %) achieved average response and 1 patient (4.8%) no response in magnetic resonance imaging in magnetic resonance imaging assessments. Mean VAS scores after treatment for 1 month: 1.4; 3 months: 0.9; 6 months: 1.1, min: 0, max: 5. The long- term recurrence rates with follow-up time from 1 to 2 years is: 3/4 patients had
recurrence (75 %) include of 1 patients had increasing imaging and pain score, 2 patients just had only increase imaging in MRI.
Conclusion: Flouroscopy-guided sclerotherapy is a safe and effective procedure to reduce size and pain for patient with venous
malformations that have symptoms. But the long – term recurrence rates is quite high.

Article Details

References

1. Dubois J., Soulez G., Oliva V.L., et al. (2001). Soft-Tissue Venous Malformations in Adult Patients: Imaging and Therapeutic Issues. RadioGraphics, 21(6), 1519–1531.
2. Buckmiller L.M., Richter G.T., and Suen J.Y. (2010). Diagnosis and management of hemangiomas and vascular malformations of the head and neck. Oral Diseases, 16(5), 405–418.
3. Nguyễn Hồng Hà, T.X.T, Trần Thị Thanh Huyền, Vũ Trung Trực, Bùi Mai Anh, Đào Văn Giang, Đỗ Thị Ngọc Linh (2013). Kết quả bước đầu điều tị tiêm xơ dị dạng tĩnh mạch bằng Polidocanol. Y học Thực hành - Journal of Practical Medicine, 869(5), 85-88.
4. Stefan Puig, Hussein Aref, Valerie Chigot, et al. (2003). Classification of venous malformations in children and implications for sclerotherapy. Pediatric Radiology, 33(2), 99–103.
5. Puig S., Aref H., Chigot V., et al. (2003). Classification of venous malformations in children and implications for sclerotherapy. Ped Radiol, 33(2), 99–103.
6. Li L., Zeng X.-Q., and Li Y.-H. (2010). Digital Subtraction Angiography–Guided Foam Sclerotherapy of Peripheral Venous Malformations. American Journal of Roentgenology, 194(5), W439–W444.
7. Pain rating scales. 4.
8. Behravesh, S., et al., (2016). Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther, 6(6), 557–569.
9. Li J., Chen J., Zheng G., et al. (2010). Digital Subtraction Angiography-Guided Percutaneous Sclerotherapy of Venous Malformations With Pingyangmycin and/or Absolute Ethanol in the Maxillofacial Region. Journal of Oral and Maxillofacial Surgery, 68(9), 2258–2266.
10. Jarrett, D.Y., M. Ali, and G. Chaudry (2013). Imaging of vascular anomalies. Dermatol Clin, 31(2), 251–66.
11. C.J., et al., van der V. (2014). Effectiveness of sclerotherapy, surgery, and laser therapy in patients with venous malformations: a systematic review. Cardiovasc Intervent Radiol, 37(4), 977–89.